221
Views
24
CrossRef citations to date
0
Altmetric
Research Article

The Dietary Supplement Protandim® Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice

, MD, MPH, , MS, , MA, , BA, , , BS, BPharm, , PhD & , MD, PhD show all
Pages 159-178 | Published online: 13 May 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bifeng Gao, An Doan & Brooks M Hybertson. (2014) The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders. Clinical Pharmacology: Advances and Applications 6, pages 19-34.
Read now

Articles from other publishers (23)

Lejla Alic, John F. GriffinIVIV, Aydin Eresen, Joe N. Kornegay & Jim X. Ji. (2021) Using MRI to quantify skeletal muscle pathology in Duchenne muscular dystrophy: A systematic mapping review. Muscle & Nerve 64:1, pages 8-22.
Crossref
Brigida Boccanegra, Ingrid E.C. Verhaart, Ornella Cappellari, Elizabeth Vroom & Annamaria De Luca. (2020) Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks. Pharmacological Research 158, pages 104917.
Crossref
Jessica R. C. Priestley, Katie E. Fink, Joe M. McCord & Julian H. Lombard. (2019) NRF 2 activation with Protandim attenuates salt‐induced vascular dysfunction and microvascular rarefaction . Microcirculation 26:7.
Crossref
Peter P. Nghiem, Joe N. Kornegay, Kitipong Uaesoontrachoon, Luca Bello, Ying Yin, Akanchha Kesari, Priya Mittal, Scott J. Schatzberg, Gina M. Many, Norman H. Lee & Eric P. Hoffman. (2017) Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells. Muscle & Nerve 56:6, pages 1119-1127.
Crossref
L. N. Porokhovnik & V. M. Pisarev. (2017) Association of polymorphisms in NFE2L2 gene encoding transcription factor Nrf2 with multifactorial diseases. Russian Journal of Genetics 53:8, pages 851-864.
Crossref
Ihsan Ullah, Fazal Subhan, Zengbing Lu, Sze Wa Chan & John A. Rudd. (2017) Action of Bacopa monnieri to antagonize cisplatin-induced emesis in Suncus murinus (house musk shrew). Journal of Pharmacological Sciences 133:4, pages 232-239.
Crossref
Л.Н. Пороховник & В.М. Писарев. (2017) СВЯЗЬ АЛЛЕЛЬНЫХ ВАРИАНТОВ ГЕНА ТРАНСКРИПЦИОННОГО ФАКТОРА Nrf2 С ПАТОГЕНЕЗОМ МНОГОФАКТОРНЫХ ЗАБОЛЕВАНИЙ, "Генетика". Генетика:8, pages 895-910.
Crossref
Keryn Woodman, Chantal Coles, Shireen Lamandé & Jason White. (2016) Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture. Nutrients 8:11, pages 713.
Crossref
Seteena L. Ueberschlag, James R. Seay, Alexandra H. Roberts, Pamela C. DeSpirito, Jeremy M. Stith, Rodney J. Folz, Kathleen A. Carter, Edward P. Weiss & Gerald S. Zavorsky. (2016) The Effect of Protandim® Supplementation on Athletic Performance and Oxidative Blood Markers in Runners. PLOS ONE 11:8, pages e0160559.
Crossref
Karen Heyninck, Linde Sabbe, Chandra Sekhar Chirumamilla, Katarzyna Szarc vel Szic, Pieter Vander Veken, Kristien J.A. Lemmens, Maija Lahtela-Kakkonen, Stefan Naulaerts, Ken Op de Beeck, Kris Laukens, Guy Van Camp, Antje R. Weseler, Aalt Bast, Guido R.M.M. Haenen, Guy Haegeman & Wim Vanden Berghe. (2016) Withaferin A induces heme oxygenase (HO-1) expression in endothelial cells via activation of the Keap1/Nrf2 pathway. Biochemical Pharmacology 109, pages 48-61.
Crossref
Jillian Davis, Emily Samuels & Lucille Mullins. (2015) Nutrition Considerations in Duchenne Muscular Dystrophy. Nutrition in Clinical Practice 30:4, pages 511-521.
Crossref
Delira Robbins & Yunfeng Zhao. 2014. Systems Biology of Free Radicals and Antioxidants. Systems Biology of Free Radicals and Antioxidants 3753 3769 .
Barry Braun & Benjamin F. Miller. 2013. The Encyclopaedia of Sports Medicine. The Encyclopaedia of Sports Medicine 453 465 .
Christina Lisk, Joe McCord, Swapan Bose, Tim Sullivan, Zoe Loomis, Eva Nozik-Grayck, Thies Schroeder, Karyn Hamilton & David C. Irwin. (2013) Nrf2 activation: A potential strategy for the prevention of acute mountain sickness. Free Radical Biology and Medicine 63, pages 264-273.
Crossref
Akinori Nakamura, Masanori Kobayashi, Mutsuki Kuraoka, Katsutoshi Yuasa, Naoko Yugeta, Takashi Okada & Shin'ichi Takeda. (2013) Initial Pulmonary Respiration Causes Massive Diaphragm Damage and Hyper-CKemia in Duchenne Muscular Dystrophy Dog. Scientific Reports 3:1.
Crossref
Kyrras Conrad, Michael Spano & Michael D. Seidman. (2013) Complementary and Integrative Treatments. Otolaryngologic Clinics of North America 46:3, pages 277-294.
Crossref
N. K. Zenkov, E. B. Menshchikova & V. O. Tkachev. (2013) Keap1/Nrf2/ARE redox-sensitive signaling system as a pharmacological target. Biochemistry (Moscow) 78:1, pages 19-36.
Crossref
A M Bataille & J E Manautou. (2012) Nrf2: A Potential Target for New Therapeutics in Liver Disease. Clinical Pharmacology & Therapeutics 92:3, pages 340-348.
Crossref
Khalid Rauf, Fazal Subhan & Robert D. E. Sewell. (2011) A Bacoside Containing Bacopa monnieri Extract Reduces Both Morphine Hyperactivity Plus the Elevated Striatal Dopamine and Serotonin Turnover . Phytotherapy Research 26:5, pages 758-763.
Crossref
Brooks M. Hybertson, Bifeng Gao, Swapan K. Bose & Joe M. McCord. (2011) Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation. Molecular Aspects of Medicine 32:4-6, pages 234-246.
Crossref
Khalid Rauf, Fazal Subhan, Muzaffar Abbas, Amir Badshah, Ihsan Ullah & Sami Ullah. (2011) Effect of Bacopasides on acquisition and expression of morphine tolerance. Phytomedicine 18:10, pages 836-842.
Crossref
Delira Robbins & Yunfeng Zhao. (2011) The Role of Manganese Superoxide Dismutase in Skin Cancer. Enzyme Research 2011, pages 1-7.
Crossref
Lucio G. Costa, Gennaro Giordano & Clement E. Furlong. (2011) Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: The hunt goes on. Biochemical Pharmacology 81:3, pages 337-344.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.